Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
AstraZeneca, BMS Plan Job Cuts
July 30, 2007
| A version of this story appeared in
Volume 85, Issue 31
AstraZeneca has announced another round of job eliminations to complement the cut of 3,000 manufacturing jobs it announced earlier this year. The British drugmaker now says it will eliminate about 700 positions in R&D, 1,800 positions in sales and marketing, and 1,800 positions in information systems and business support. Separately, Bristol-Myers Squibb said last week that it will announce job cuts and facilities closures later this year as part of its own streamlining effort.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter